Journal for ImmunoTherapy of Cancer (Nov 2020)

407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors

  • Adil Daud,
  • Rom Leidner,
  • Ezra Cohen,
  • Matthew Reilley,
  • Siwen Hu-Lieskovan,
  • Raphael Clynes,
  • Roger Cohen,
  • John Thompson,
  • Mark Stein,
  • Alain Mita,
  • Bartosz Chmielowski,
  • Yana Najjar,
  • Elaine Shum,
  • R Donald Harvey,
  • Catherine Fleener,
  • Ying Ding,
  • Sowmya Chollate,
  • Hector Avina,
  • Jolene Shorr,
  • Barbara Hickingbottom

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0407
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.